Clene Statistics
Total Valuation
Clene has a market cap or net worth of $44.06 million. The enterprise value is $56.74 million.
| Market Cap | 44.06M |
| Enterprise Value | 56.74M |
Important Dates
The next estimated earnings date is Thursday, November 12, 2026, before market open.
| Earnings Date | Nov 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Clene has 14.21 million shares outstanding. The number of shares has increased by 35.38% in one year.
| Current Share Class | 14.21M |
| Shares Outstanding | 14.21M |
| Shares Change (YoY) | +35.38% |
| Shares Change (QoQ) | +6.34% |
| Owned by Insiders (%) | 11.27% |
| Owned by Institutions (%) | 24.06% |
| Float | 11.65M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 223.67 |
| Forward PS | 184.21 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 288.00 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.07
| Current Ratio | 3.07 |
| Quick Ratio | 2.24 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -7.13 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -56.88% |
| Return on Invested Capital (ROIC) | -260.46% |
| Return on Capital Employed (ROCE) | -112.99% |
| Weighted Average Cost of Capital (WACC) | 9.60% |
| Revenue Per Employee | $2,494 |
| Profits Per Employee | -$500,228 |
| Employee Count | 79 |
| Asset Turnover | 0.01 |
| Inventory Turnover | 1.02 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -65.13% in the last 52 weeks. The beta is 0.92, so Clene's price volatility has been similar to the market average.
| Beta (5Y) | 0.92 |
| 52-Week Price Change | -65.13% |
| 50-Day Moving Average | 4.07 |
| 200-Day Moving Average | 5.28 |
| Relative Strength Index (RSI) | 27.01 |
| Average Volume (20 Days) | 98,683 |
Short Selling Information
The latest short interest is 880,688, so 6.20% of the outstanding shares have been sold short.
| Short Interest | 880,688 |
| Short Previous Month | 915,634 |
| Short % of Shares Out | 6.20% |
| Short % of Float | 7.56% |
| Short Ratio (days to cover) | 6.15 |
Income Statement
In the last 12 months, Clene had revenue of $197,000 and -$39.52 million in losses. Loss per share was -$3.50.
| Revenue | 197,000 |
| Gross Profit | 138,000 |
| Operating Income | -20.55M |
| Pretax Income | -39.52M |
| Net Income | -39.52M |
| EBITDA | -19.12M |
| EBIT | -20.55M |
| Loss Per Share | -$3.50 |
Balance Sheet
The company has $9.67 million in cash and $22.34 million in debt, with a net cash position of -$12.67 million or -$0.89 per share.
| Cash & Cash Equivalents | 9.67M |
| Total Debt | 22.34M |
| Net Cash | -12.67M |
| Net Cash Per Share | -$0.89 |
| Equity (Book Value) | -24.78M |
| Book Value Per Share | -1.94 |
| Working Capital | 10.06M |
Cash Flow
In the last 12 months, operating cash flow was -$15.91 million and capital expenditures -$40,000, giving a free cash flow of -$15.95 million.
| Operating Cash Flow | -15.91M |
| Capital Expenditures | -40,000 |
| Depreciation & Amortization | 1.43M |
| Net Borrowing | 1.11M |
| Free Cash Flow | -15.95M |
| FCF Per Share | -$1.12 |
Margins
| Gross Margin | 70.05% |
| Operating Margin | -10,431.98% |
| Pretax Margin | -20,059.90% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Clene does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -35.38% |
| Shareholder Yield | -35.38% |
| Earnings Yield | -89.68% |
| FCF Yield | -36.19% |
Analyst Forecast
The average price target for Clene is $32.20, which is 938.71% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $32.20 |
| Price Target Difference | 938.71% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | 832.87% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on July 11, 2024. It was a reverse split with a ratio of 1:20.
| Last Split Date | Jul 11, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
Clene has an Altman Z-Score of -21.61 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -21.61 |
| Piotroski F-Score | 2 |